Andere Kunden interessierten sich auch für
![Induced Defenses by Nonpathogenic Fungi Against Fungal Plant Diseases]( "Induced Defenses by Nonpathogenic Fungi Against Fungal Plant Diseases")
Induced Defenses by Nonpathogenic Fungi Against Fungal Plant Diseases58,99 €![Cross-Border Conflict and Gendered Implications for Local Communities]( "Cross-Border Conflict and Gendered Implications for Local Communities")
Cross-Border Conflict and Gendered Implications for Local Communities33,99 €![Increasing screening uptake to fight against chronic diseases]( "Increasing screening uptake to fight against chronic diseases")
Increasing screening uptake to fight against chronic diseases32,99 €![Prevalence of allergic diseases and asthma]( "Prevalence of allergic diseases and asthma")
Prevalence of allergic diseases and asthma36,99 €![Obtaining a turmeric-added wafer as an adjuvant treatment for chronic inflammatory diseases]( "Obtaining a turmeric-added wafer as an adjuvant treatment for chronic inflammatory diseases")
Obtaining a turmeric-added wafer as an adjuvant treatment for chronic inflammatory diseases29,99 €![Review of my researches regarding diseases in Iraq]( "Review of my researches regarding diseases in Iraq")
Review of my researches regarding diseases in Iraq15,99 €![Analysis of civil society's contribution to development]( "Analysis of civil society's contribution to development")
Analysis of civil society's contribution to development68,99 €
Adiponectin is the name originated from its distinctive molecular characteristics ("adipo" + "nectin" = "adiponectin") as it is a product of novel gene apM1 which is specific to adipocytes and uniquely possess a collagen-like domain with a nectin-like adherent property. Adiponectin is the most abundant peptide secreted by adipocytes, whose altered levels play a central role in obesity-related diseases, including insulin resistance/type 2 diabetes and cardiovascular disease. It is known to exert anti-diabetic and anti-atherosclerotic effects via adiponectin receptors (Adipors); AdipoR1 and AdipoR2. Adiponectin has direct actions in liver, skeletal muscle and the vasculature. Adiponectin administration in humans and rodents has insulin-sensitizing, anti-atherogenic, and anti-in ammatory effects and in certain settings, also decreases body weight. Therefore, adiponectin replacement therapy in humans may suggest potential versatile therapeutic targets in the treatment of obesity, insulin resistance/type 2 diabetes, cardiovascular disease and atherosclerosis.